Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Genomics Research Highlighted at Lupus Conference

Larry Beresford  |  Issue: June 2019  |  June 17, 2019

The Death-Associated Protein

Prithvi Raj, PhD, assistant professor in the Department of Immunology at UT Southwestern Medical Center, Dallas, reported on his group’s research in targeted sequencing of 1,200 lupus patients, which has identified a region around the death-associated protein 1 (DAP1) regulatory haplotype.4 Haplotypes are a group of genes inherited together from a single parent, and Dr. Raj’s group is studying how the DAP1 regulatory haplotype potentiates autoimmunity, different DAP expressions and the endophenotype for autoimmunity.

Joann Sweasy, PhD, ensign professor of therapeutic radiology at Yale University School of Medicine, New Haven, Conn., reported on an association of a coding variant in MSH6, a gene part of the cellular machinery that repairs DNA, and the risk of SLE in an exome-wide association study.5 “We looked at a list of DNA repair genes, looking for coding variants,” Dr. Sweasy said. Her group has created a mouse model with this variant. Full characteri­zation of the mice is still in process, but the researchers are producing anti-nuclear antibodies. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Larry Beresford is a medical journalist in Oakland, Calif.

References

  1. Alarcón-Riquelme ME. From genetics to genomics: Using multi-omic integrative analysis to reclassify lupus and other systemic autoimmune diseases. Abstract presentation at the 13th International Congress on Systemic Lupus Erythematosus, San Francisco. 2019 Apr 6.
  2. Niewold TB. Sub-phenotype mapping and functional studies to understand lupus genetics. Abstract presentation at 13th International Congress on Systemic Lupus Erythematosus, San Francisco. 2019 Apr 6.
  3. Shen N. Understanding the contributions of novel regulatory elements in human genome to lupus. Abstract presentation at 13th International Congress on Systemic Lupus Erythematosus, San Francisco. 2019 Apr 6.
  4. Raj P, Song R, Riediger L, et al. Targeted sequencing in 1,200 SLE patients reveal DAP1 regulatory haplotype that potentiate autoimmunity. Abstract presentation at 13th International Congress on Systemic Lupus Erythematosus, San Francisco. 2019 Apr 6.
  5. Sweasy JB, Meas R, Nititham J, et al. A mismatch repair genetic variant is linked to the development of lupus. Abstract presentation at 13th International Congress on Systemic Lupus Erythematosus, San Francisco. 2019 Apr 6.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:epigeneticsgenomic researchgenomicsInternational Congress of Lupus

Related Articles

    The Type I Interferon Pathway’s Influence in Connective Tissue Disease

    July 18, 2019

    Type I interferon appears to play a role in disease susceptibility and pathogenesis in several classic connective tissue diseases, at least in some patients. Below, I present evidence supporting this connection, explore potential missing links in pathogenesis and discuss biological treatments that target the pathway. The Type I Interferon Pathway Interferons are a class of…

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    Genome-Wide Association Studies of SLE

    February 12, 2011

    What do these studies tell us about disease mechanisms in lupus?

    Research Advances Continue in the Fight Against Lupus

    June 17, 2019

    SAN FRANCISCO—The 13th International Congress on Systemic Lupus Erythematosus (SLE), held April 5–8, highlighted continuing advances in the fight against lupus, a chronic, inflammatory, autoimmune disease affecting multiple organ systems. The rheumatologist’s ability to control this incurable and life-threatening condition is limited both by its heterogeneous presentation and by the lack of successful treatment options,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences